{
    "code": "52026583",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026583",
    "time": "2021-02-12 04:05:52",
    "許可證字號": "衛部藥輸字第026583號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "110\/01\/07",
    "發證日期": "105\/01\/07",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "null",
    "中文品名": "&quot;紐申達&quot;緩釋錠 50毫克",
    "英文品名": "Nucynta Extended Release Tablets 50 mg",
    "適應症": "(1)需要長期疼痛控制之中重度癌症疼痛病患。 (2)需要長期疼痛控制之的慢性中重度非癌症疼痛病患，且曾經接受過類鴉片藥物而無法有效控制疼痛者。本品未核准用於急性疼痛控制，故不適合作為視需要給予(PRN，pro re nata)之止痛藥。",
    "劑型": "116膜衣錠",
    "包裝": "20-1000錠PVC\/ACLAR鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "B第二級管制藥品",
    "藥品分類": "",
    "監視期限": "110\/01\/07",
    "主成分略述": "Tapentadol hydrochloride",
    "限制項目": "02輸　入 1D須執行風險管理計畫 1Q不得輸入 32第二級管制藥品 51免除銜接性臨床試驗",
    "申請商名稱": "6201180767  衛生福利部食品藥物管理署管制藥品製藥工廠",
    "申請商地址": "台北市南港區忠孝東路六段467號地下一層",
    "主製造廠": [
        {
            "製造廠名稱": "FPR0036000  JANSSEN ORTHO LLC",
            "製造廠廠址": "STATE ROAD 933 KM 0.1, MAMEY WARD, GURABO, PUERTO RICO, 00778-9629",
            "製造廠公司地址": "CILAG A.G., HOCHSTRASSE 201, CH-8205 SCHAFFHAUSEN, SWITZERLAND",
            "製造廠國別": "PUERTO RICO",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808202710",
            "成分名稱": "Tapentadol hydrochloride",
            "含量描述": "(eq to Tapentadol......50MG)",
            "含量": "58.2400000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "紐申達NUCYNTA緩釋錠(ER)中文仿單-29.7x66cm-20151229 Hi-105-07-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026583&Seq=001&Type=9"
        },
        {
            "title": "1.6.2 NUCYNTA ER 50MG-carton-10249600-105-07-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026583&Seq=002&Type=8"
        }
    ]
}